BIOGEN INC.
Customers
0
None disclosed
Suppliers
1
0 active
Latest period
Dec 31, 2024
10-K filed 2026-02-25
Suppliers 1
Companies that disclose BIIB as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from BIIB | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| ALKS Alkermes plc. |
11% | $171.3M | FY 2024-12-31 | ±0.0pp | Lapsed Last seen 2024-12-31 |
10-K 2026-02-25 |
The following represents revenue and receivables from the Company’s customers exceeding 10% of the total in each category as of, and for the years ended, December 31, 2025, 2024 and 2023: Year Ended December 31, 2025 2024 2023 Customer Receivables Revenue Receivables Revenue Receivables Revenue McKesson 33 % 31 % 36 % 25 % 14 % 14 % Cencora 26 % 20 % 17 % 15 % 16 % 12 % Cardinal Health 17 % 17 % 16 % 19 % 24 % 20 % Janssen 12 % * 14 % 17 % 23 % 31 % Biogen * * * 11 % * 11 % * Indicates the revenues or receivables for the customer did not exceed 10% of the Company’s total in each category as of or for the years ended December 31, 2025, 2024 and 2023, as noted. | ||||||
Alerts are coming
Get an email when BIIB's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.